Anzeige
Mehr »
Login
Mittwoch, 29.01.2020 Börsentäglich über 12.000 News von 622 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:20J&J warns biosimilars will bite after muted impact in 2019
DiBellicum offloads cell therapy plant in switch to outsourced production
DiLonza poised to add 600 staff as investment peak continues into 2020
DiKrystal Biotech continues internal buildout with second facility
MoNew CDMO plans $1.1bn cell and gene therapy plant
FrLarge pharma focusing on in-house biologic manufacture, not outsourcing
DoGE Healthcare anticipates demand with Swiss facility investment
DoPACT Pharma raises $75M to expand cell therapy manufacturing
22.01.Number of UK clinical trials of cell and gene therapies explodes
22.01.Celltrion set to build largest biopharma plant in China
22.01.Health plan hails success of push to boost Remicade biosimilar use
21.01.Sarepta tips Roche pact to spur manufacturing capacity expansion
20.01.Merck looks to CMOs to help ease vaccine supply bottleneck
20.01.Nationwide Children's Hospital creates for-profit gene therapy CMO
17.01.Failure to launch? Mixed views on US biosimilar market
16.01.WuXi Biologics acquires first EU drug product facility through Bayer deal
16.01.Commercial manufacture of Bluebird's gene therapy begins, launched in Germany
15.01.Astellas continues to make deals, partnering with Adaptimmune
15.01.Lilly acquires Dermira for $1.1bn, expands dermatology portfolio
14.01.Biocon biosimilar business valued at $3bn in funding round
14.01.FDA places Innate cancer trial on partial clinical hold over CMO issue
14.01.Yposkesi doubles manufacturing footprint to meet growing demand on AAVs
13.01.Bristol-Myers offloads manufacturing plant to Catalent
13.01.Industry equipment is causing a 'data deficit', says Fujifilm exec
09.01.Astellas acquires Xyphos and its CAR-T technology for $665m